A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT07541170 · RECRUITING
Trial details
- NCT number
- NCT07541170
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2032-01-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.